Refine
Year of publication
Document Type
- Article (47)
Language
- English (47)
Has Fulltext
- yes (47)
Is part of the Bibliography
- no (47)
Keywords
- Student (10)
- India (8)
- Knowledge (8)
- Mumbai (8)
- Wissen (8)
- Indien (6)
- University students (6)
- Antibiotikum (5)
- HIV (5)
- Antibiotic resistance (4)
- Klinisches Experiment (4)
- Pakistan (4)
- clinical research (4)
- Arzneimittelresistenz (3)
- Attitude (3)
- Karachi (3)
- Pharmaziestudent (3)
- USA (3)
- African socio-cultural context (2)
- Afrika (2)
- Aids (2)
- Antibiotic (2)
- Antibiotics (2)
- Diabetes mellitus (2)
- Einstellung (2)
- Karatschi (2)
- Lebensqualität (2)
- Mumbai, India (2)
- Mundhöhlenkrebs (2)
- Nigeria (2)
- Oral cancer (2)
- Pharmacy (2)
- Rauchen (2)
- Selbstmedikation (2)
- Self-medication (2)
- Smoking (2)
- Students (2)
- Tabakkonsum (2)
- Tobacco (2)
- cost-effectiveness (2)
- developing countries (2)
- modifiable characteristics of the vulnerable patients (2)
- Adult Vaccines (1)
- Adverse drug event (1)
- Adverse drug reaction (1)
- Aerobes Training (1)
- Aerobic exercise (1)
- African countries (1)
- Antidiabetic (1)
- Antidiabetikum (1)
- Antiretroviral therapy (1)
- App <Programm> (1)
- Approval (1)
- Approvals (1)
- Arzneimittel (1)
- Arzneimittelnebenwirkung (1)
- Arzneimittelüberwachung (1)
- Automobile spray painters (1)
- Awareness (1)
- Berufskrankheit (1)
- Bewegungstherapie (1)
- Blutspende (1)
- CD4+ cell count (1)
- Cardiorespiratory function (1)
- Cell phone (1)
- Cement workers (1)
- Childhood febrile conditions (1)
- Chronische Niereninsuffizienz (1)
- Cleaners (1)
- Clinical Trials (1)
- Clinical trial (1)
- Communication (1)
- Community-dwelling older adults (1)
- Cost-effectiveness (1)
- DALY (1)
- Data quality control (1)
- Datenqualität (1)
- Declaration of Helsinki (1)
- Depression (1)
- Developing Countries (1)
- Diabetes mellitus Typ 2 (1)
- Diabetic wound healing (1)
- Discriminatory power (1)
- Disease Burden (1)
- Disease burden (1)
- Drogenmissbrauch (1)
- E-cadherin (1)
- Ebola-Virus (1)
- Economic and political/governmental infrastructural factors (1)
- Education (1)
- Educational intervention (1)
- Effizienz (1)
- Entscheidungsfindung (1)
- Entwicklungsländer (1)
- Epilepsie (1)
- Epilepsy (1)
- European Union (1)
- Exercise training (1)
- Fahrzeuglackierer (1)
- Falls (1)
- Fraktionierung (1)
- Genehmigung (1)
- Germany (1)
- Gesundheitswesen (1)
- Grand mean (1)
- HAART (1)
- HIV-Infektion (1)
- HIV/AIDS (1)
- HPV (1)
- Haematological parameters (1)
- Handy (1)
- Health services (1)
- Heil- und Hilfsmittel (1)
- Holzarbeiter (1)
- Humanes Papillomavirus (1)
- Hygiene (1)
- ICH-GCP (1)
- Impfstoff (1)
- Impfung (1)
- Income (1)
- Indonesia (1)
- Infrastruktur (1)
- Kardiopulmonale Leistungsfähigkeit (1)
- Knochenbruch (1)
- Knochendichte (1)
- Krafttraining (1)
- Krampf (1)
- Krankenhaus (1)
- Körperliche Leistungsfähigkeit (1)
- Luftqualität (1)
- Ländlicher Raum (1)
- Maharashtra (1)
- Matunga (1)
- Mechanism (1)
- Medical Ethics (1)
- Medical devices (1)
- Medical expertise (1)
- Medication adherence (1)
- Mental health (1)
- Metaanalyse (1)
- Mitigation plan (1)
- Monitoring (1)
- Mothers’ perception of recovery (1)
- Mothers’ satisfaction (1)
- Multicenter clinical trials (1)
- Nanomedicine (1)
- Nanotechnology (1)
- Nanotoxicity (1)
- Occupational-specific variations (1)
- Osteoporose (1)
- Patent medicine dealers (1)
- Patient (1)
- Patient satisfaction (1)
- Perception (1)
- Pharmacists (1)
- Pharmacovigilance (1)
- Pharmazeut (1)
- Pharmazeutische Industrie (1)
- Pharmazie (1)
- Physical activity level (1)
- Physical exercise adherence (1)
- Physikalische Therapie (1)
- Physiotherapeut (1)
- Piper crocatum Ruiz & Pav (1)
- Poststroke depression (1)
- Psychische Gesundheit (1)
- Quality of Life (1)
- Quality of life (1)
- Raigad (1)
- Rational drug use (1)
- Registrierung (1)
- Registry data (1)
- Regulations (1)
- Reliability (1)
- Resistance (1)
- Resistance exercise (1)
- Resistenz (1)
- Risikoanalyse (1)
- Risk methodology assessment (1)
- Risk-based monitoring (1)
- Rural community (1)
- SMS <Telekommunikation> (1)
- SOD1 (1)
- Schlaganfallpatient (1)
- Schulung (1)
- Seizures (1)
- Selbstmanagement (1)
- Social participation (1)
- Spanien (1)
- Stadt (1)
- Sturz (1)
- Symptom (1)
- Symptoms of post-stroke depression (1)
- Systematic review (1)
- Tala (1)
- Teilhabe (1)
- Text-message (1)
- Therapietreue (1)
- Timed-up-and-go test (1)
- USFDA (1)
- Unerwünschte Arzneimittelwirkung (1)
- University Students (1)
- Vaccine (1)
- Validity (1)
- Velocity field diagram (1)
- Voluntary blood donation (1)
- Woodworkers (1)
- Wundheilung (1)
- Yogyakarta (1)
- Zufriedenheit (1)
- adult vaccines (1)
- antidiabetic (1)
- antihypertensive (1)
- belief (1)
- bioethics (1)
- biomedicine (1)
- bone mineral density (1)
- chronic kidney disease (1)
- clinical trial (1)
- clinical trials (1)
- culture (1)
- data protection (1)
- dentist (1)
- developing country (1)
- diabetes mellitus (1)
- education (1)
- ethnomedicine (1)
- fracture (1)
- healing (1)
- healthcare systems (1)
- hypertension (1)
- income (1)
- medical data (1)
- medicine registrations (1)
- meta-analysis (1)
- mobile health apps (1)
- musculoskeletal disorders, (1)
- non-prescription (1)
- occupational disorders (1)
- osteoporosis (1)
- p53 (1)
- performance of the pharmaceutical industry (1)
- placebo (1)
- questionnaire (1)
- roads to health (1)
- self-management (1)
- self-medication (1)
- self-prescription (1)
- standard of care (1)
- survey (1)
- symptoms of post-stroke depression (1)
- university students (1)
- Älterer Mensch (1)
Institute
Nanotechnology is emerging as one of the key technologies of the 21st century and is expected to enable developments across a wide range of sectors that can benefit citizens. Nanomedicine is an application of nanotechnology in the areas of healthcare, disease diagnosis, treatment and prevention of disease. Nanomedicines pose problem of nanotoxicity related to factors like size, shape, specific surface area, surface morphology, and crystallinity. Currently, nanomedicines are regulated as medicinal products or as medical devices and there is no specific regulatory framework for nanotechnology-based products neither in the EU nor in the USA. This review presents a scheme for classification and regulatory approval process for nanotechnology based medicines.
The world health organization defines musculoskeletal disorder (MSD) as “a disorder of muscles, tendons, peripheral vascular system not directly resulting from an acute or instantaneous event.1 Work related MSDs are one of the most important occupational hazards.1 Among many other occupations, dentistry is a highly demanding profession that requires good visual acuity, hearing, depth perception, psychomotor skills, manual dexterity, and ability to maintain occupational postures over long periods.
Immunization is the most cost-effective intervention for infectious diseases, which are the major cause of morbidity and mortality worldwide. Vaccines not only protect the individual who is vaccinated but also reduce the burden of infectious vaccine-preventable diseases for the entire community.
1 Adult vaccination is very important given that >25% of mortality is due to infectious diseases.
2 There is a scarcity of information on the vaccination status of young adults and the role of socioeconomic conditions in India.
Introduction: Piper crocatum Ruiz & Pav (P. crocatum) has been reported to accelerate the diabetic wound healing process empirically. Some studies showed the benefits of P. crocatum in treating various diseases but its mechanisms in diabetic wound healing have never been reported. In the present study we investigated the diabetic wound healing activity of the active fraction of P. crocatum on wounded hyperglycemia fibroblasts (wHFs).
Methods: Bioassay-guided fractionation was performed to get the most active fraction. The selected active fraction was applied to wHFs within 72 h incubation. Mimicking a diabetic condition was done using basal glucose media containing an additional 17 mMol/L D-glucose. A wound was simulated via the scratch assay. The collagen deposition was measured using Picro-Sirius Red and wound closure was measured using scratch wound assay. Underlying mechanisms through p53, aSMA, SOD1 and Ecadherin were measured using western blotting.
Results: We reported that FIV is the most active fraction of P. crocatum. We confirmed that FIV\(7.81 mg/ml, 15.62 mg/ml, 31.25 mg/ml, 62.5 mg/ml, and 125 mg/ml) induced the collagen deposition and wound closure of wHFs. Furthermore, FIV treatment (7.81 mg/ml, 15.62 mg/ml, 31.25 mg/ml) down-regulated the protein expression level of p53 and up-regulated the protein expression levels of aSMA, E-cadherin, and SOD1.
Discussion/conclusions: Our findings suggest that ameliorating collagen deposition and wound closure through protein regulation of p53, aSMA, E-cadherin, and SOD1 are some of the mechanisms by which FIV of P. crocatum is involved in diabetic wound healing therapy.
Background: The globalization of clinical research should also benefit the population in developing markets. In this context, the approval of tested medicines and the associated expansion of medical care beyond clinical studies would be desirable as a possible long-term benefit.
Objectives: This study was designed to compare the development of the number of clinical trials with the number of marketing authorizations of medicines on the African continent. To contrast these 2 parameters, the data were analyzed using the model of an ecological study.
Methods: To reflect the broad spectrum of African developing countries with diverse levels of development, the data collection was based on 2 geographically selected sample countries each from Central, North, East, West, and Southern Africa. Based on the ClinicalTrials.gov registry, the first step was to collect trends data on the development of the clinical trials in the 10 selected countries of the country list of the African Region published by the World Health Organization for the period 2015 to 2018. Subsequently, data on the current number of marketing authorizations of medicines in the selected sample countries were identified using the online registries of the national authorities. The data were utilized in comparative analyses.
Results: Eight out of 10 model countries showed an increase in the number of clinical trials, with the exceptions of Cameroon and Libya, which showed an overall decline in research activity over the entire time. In direct comparison with drug registrations, the numbers indicate a similar development. The only exception here is Nigeria, a country with a solid performance in clinical research and yet a decrease in medicine registrations since 2015.
Conclusions: The expected increase in the development of clinical research as result of the globalization trend can basically be observed in most of the model countries. However, this increase does not guarantee an improvement in the number of medicine registrations. Although this is evident in some of the selected model countries, it cannot be projected to the entire African region. This may be linked to the diverse development of the individual countries due to the different political situations and the varying degrees of clinical research infrastructure.
Economic and political/governmental infrastructural factors are major contributors to the economic development/growth of all sectors of a country, such as in the area of healthcare systems and clinical research, including the pharmaceutical industry. But what is the interaction between economic, and political/governmental infrastructural factors and the development of healthcare systems, especially, the performance of the pharmaceutical industry? Information from selected articles of a literature search of PubMed and by using Google Advanced Search led to the generation of five categories of infrastructural factors, and were filled with data from 41 African Countries using the World Health Organization data repository. Median changes over time were given and tested by Wilcoxon signed-rank test and Friedman test, respectively. Analysis of factors related to availability of healthcare facilities showed that physicians and pharmacies were significant increased, with insignificantly decreased number of hospital beds. Healthcare Financing by the Government showed notable differences. Private health spending decreased significantly unlike Gross National Income. Analysis of infrastructural factors showed that stable supply of electricity and the associated use of the Internet improved significantly. The low level of data on the expansion of paved road networks suggests less developed medical services in remote rural areas. Healthcare systems in African countries improved over the last two decades, but differences between the individual countries still prevail and some of the countries cannot yet offer an attractive sales market for the products of pharmaceutical companies.
Ever since the 1996 revision of the Declaration of Helsinki, the World Medical Association has attempted to address ethical and scientific concerns of its diverse stakeholders for Articles 33 (use of placebo) and 34 (posttrial provisions), most recently in 2013. Both are inextricably linked to standard of care, an essential element of any comparative, interventional clinical trial. But has this now 20-year-long ethical debate truly been put to rest? The choice of standard of care in clinical trials remains a complex issue, particularly for comparative trials conducted in emerging countries.